Products for Research Use Only
RegisterLogin

Otenabant

CAT: 0804-HY-10871-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-10871-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Otenabant is a potent and selective cannabinoid receptor CB1 antagonist with Ki of 0.7 nM, exhibits 10,000-fold greater selectivity against human CB2 receptor.
CAS Number
686344-29-6
Product Name Alternative
CP-945598
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Cannabinoid Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/Otenabant.html
Purity
99.23
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
ClC1=CC=CC=C1C2=NC3=C(N4CCC(NCC)(C(N)=O)CC4)N=CN=C3N2C5=CC=C(Cl)C=C5
Molecular Formula
C25H25Cl2N7O
Molecular Weight
510.42
Precautions
H302, H315, H319, H335
References & Citations
[1]John R. Hadcock, et al. In vitro and in vivo pharmacology of CP-945,598, a potent and selective cannabinoid CB1 receptor antagonist for the management of obesity. Biochemical and Biophysical Research Communications, 2010; 394;366-371.|[2]Griffith DA, et al. Discovery of 1-[9- (4-chlorophenyl) -8- (2-chlorophenyl) - 9H-purin-6-yl] -4-ethylaminopiperidine-4-carboxylic acid amide hydrochloride (CP-945,598), a novel, potent, and selective cannabinoid type 1 receptor antagonist. JMedChem. 2009 ;5
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 3

Alternative Products

CatalogName
A3691-50Otenabant
T1796-01Otenabant hydrochloride
A15200-5Otenabant 5mg
502501Otenabant HCl
MBS130085-01Otenabant (CP945598)
A15200-25Otenabant 25mg
A15200-50Otenabant 50mg
A15200-2Otenabant 2mg
A15200-100Otenabant 100mg

Popular Products